Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$105.94
-1.2%
$113.29
$89.67
$121.64
$183.82B0.745.63 million shs5.07 million shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$426.71
-1.0%
$402.04
$289.36
$433.33
$139.81B1.432.55 million shs1.82 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$90.83
-1.4%
$89.90
$69.42
$95.57
$149.83B1.438.00 million shs5.86 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-1.26%-1.52%-6.79%-6.38%-4.65%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
-0.97%+0.71%+2.16%+11.14%+25.29%
Morgan Stanley stock logo
MS
Morgan Stanley
-1.39%-3.19%-3.54%+4.10%+3.30%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9921 of 5 stars
3.35.04.24.52.62.52.5
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.6732 of 5 stars
2.44.02.53.03.12.52.5
Morgan Stanley stock logo
MS
Morgan Stanley
4.5467 of 5 stars
2.23.03.32.43.22.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5014.69% Upside
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.75
Moderate Buy$437.042.42% Upside
Morgan Stanley stock logo
MS
Morgan Stanley
2.42
Hold$98.308.23% Upside

Current Analyst Ratings

Latest MS, ABT, and GS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/30/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$479.00 ➝ $517.00
4/30/2024
Morgan Stanley stock logo
MS
Morgan Stanley
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$101.00 ➝ $105.00
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/19/2024
Morgan Stanley stock logo
MS
Morgan Stanley
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$100.00 ➝ $102.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/18/2024
Morgan Stanley stock logo
MS
Morgan Stanley
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
4/18/2024
Morgan Stanley stock logo
MS
Morgan Stanley
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$115.00 ➝ $118.00
4/17/2024
Morgan Stanley stock logo
MS
Morgan Stanley
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$100.00 ➝ $106.00
4/17/2024
Morgan Stanley stock logo
MS
Morgan Stanley
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$107.00 ➝ $109.00
4/17/2024
Morgan Stanley stock logo
MS
Morgan Stanley
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$97.00 ➝ $101.00
(Data available from 5/1/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.58$6.27 per share16.90$22.36 per share4.74
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$108.42B1.28$40.60 per share10.51$363.61 per share1.17
Morgan Stanley stock logo
MS
Morgan Stanley
$96.19B1.54$8.29 per share10.95$55.58 per share1.63

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.0020.692.5913.96%20.32%10.59%7/18/2024 (Estimated)
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.52B$25.6116.6611.001.368.17%8.65%0.58%7/17/2024 (Estimated)
Morgan Stanley stock logo
MS
Morgan Stanley
$9.09B$5.4916.5411.861.759.57%10.87%0.85%7/16/2024 (Estimated)

Latest MS, ABT, and GS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
4/16/2024Q1 24
Morgan Stanley stock logo
MS
Morgan Stanley
$1.69$2.02+$0.33$2.02$14.42 billion$15.14 billion    
4/15/2024Q1 2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.54$11.58+$3.04$11.58$12.94 billion$14.21 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.08%+12.31%68.54%53 Years
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$11.002.58%+28.06%42.95%3 Years
Morgan Stanley stock logo
MS
Morgan Stanley
$3.403.74%+32.41%61.93%3 Years

Latest MS, ABT, and GS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Quarterly$2.752.77%5/30/20245/30/20246/27/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
4/16/2024
Morgan Stanley stock logo
MS
Morgan Stanley
quarterly$0.853.8%4/29/20244/30/20245/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
1.98
1.12
0.76
Morgan Stanley stock logo
MS
Morgan Stanley
2.89
0.75
0.75

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Morgan Stanley stock logo
MS
Morgan Stanley
84.19%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.47%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.57%
Morgan Stanley stock logo
MS
Morgan Stanley
0.24%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
45,300324.53 million322.68 millionOptionable
Morgan Stanley stock logo
MS
Morgan Stanley
80,0001.63 billion1.62 billionOptionable

MS, ABT, and GS Headlines

SourceHeadline
Stock Market Crash Alert: 3 Must-Buy Financial Stocks When Prices PlungeStock Market Crash Alert: 3 Must-Buy Financial Stocks When Prices Plunge
investorplace.com - May 1 at 6:53 AM
Morgan Stanley (NYSE:MS) Price Target Increased to $105.00 by Analysts at OppenheimerMorgan Stanley (NYSE:MS) Price Target Increased to $105.00 by Analysts at Oppenheimer
americanbankingnews.com - May 1 at 4:14 AM
Whether Wall Street garden leaves survive non-compete ban is an open questionWhether Wall Street garden leaves survive non-compete ban is an 'open question'
finance.yahoo.com - May 1 at 4:10 AM
Sapient Capital LLC Sells 360,748 Shares of Morgan Stanley (NYSE:MS)Sapient Capital LLC Sells 360,748 Shares of Morgan Stanley (NYSE:MS)
marketbeat.com - May 1 at 12:04 AM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morgan Stanley and Encourages Investors with Losses to Contact the FirmINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morgan Stanley and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 30 at 9:45 PM
GVTC Recognizes Morgan Stanley as Winner of 2024 IMPACT AwardGVTC Recognizes Morgan Stanley as Winner of 2024 IMPACT Award
finance.yahoo.com - April 30 at 6:09 PM
2 Underperforming Dow Stocks That Morgan Stanley Recommends Buying Now2 Underperforming Dow Stocks That Morgan Stanley Recommends Buying Now
msn.com - April 30 at 6:09 PM
Unpacking the Latest Options Trading Trends in Morgan StanleyUnpacking the Latest Options Trading Trends in Morgan Stanley
benzinga.com - April 30 at 6:09 PM
Morgan Stanley’s $20M bonuses draw proxy adviser’s fireMorgan Stanley’s $20M bonuses draw proxy adviser’s fire
bankingdive.com - April 30 at 6:09 PM
Citi and Morgan Stanley among leaders of open-source initiative to tackle ‘common challenges’ in AICiti and Morgan Stanley among leaders of open-source initiative to tackle ‘common challenges’ in AI
finance.yahoo.com - April 30 at 1:08 PM
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? (MS)CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? (MS)
marketbeat.com - April 30 at 9:25 AM
Morgan Stanley (NYSE:MS) Price Target Raised to $105.00Morgan Stanley (NYSE:MS) Price Target Raised to $105.00
marketbeat.com - April 30 at 9:14 AM
Raymond James & Associates Increases Holdings in Morgan Stanley (NYSE:MS)Raymond James & Associates Increases Holdings in Morgan Stanley (NYSE:MS)
marketbeat.com - April 29 at 11:30 PM
Scotiabank names former Morgan Stanley exec as head of global banking, markets unitScotiabank names former Morgan Stanley exec as head of global banking, markets unit
reuters.com - April 29 at 5:07 PM
Morgan Stanley shareholders urged to vote against executive payMorgan Stanley shareholders urged to vote against executive pay
proactiveinvestors.com - April 29 at 1:45 PM
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Morgan Stanley for potential violations of federal securities lawsWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Morgan Stanley for potential violations of federal securities laws
prnewswire.com - April 29 at 1:44 PM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morgan Stanley and Encourages Investors with Losses to Contact the FirmINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morgan Stanley and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 28 at 7:45 PM
Morgan Stanley (NYSE:MS) Shares Acquired by Retirement Systems of AlabamaMorgan Stanley (NYSE:MS) Shares Acquired by Retirement Systems of Alabama
marketbeat.com - April 28 at 7:33 PM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Morgan Stanley Investors to Inquire About Securities Class Action Investigation - MSROSEN, GLOBAL INVESTOR COUNSEL, Encourages Morgan Stanley Investors to Inquire About Securities Class Action Investigation - MS
markets.businessinsider.com - April 28 at 5:00 PM
ROSEN, A LEADING LAW FIRM, Encourages Morgan Stanley Investors to Inquire About Securities Class Action Investigation - MSROSEN, A LEADING LAW FIRM, Encourages Morgan Stanley Investors to Inquire About Securities Class Action Investigation - MS
markets.businessinsider.com - April 27 at 3:56 PM
Truist Financial Corp Reduces Stock Position in Morgan Stanley (NYSE:MS)Truist Financial Corp Reduces Stock Position in Morgan Stanley (NYSE:MS)
marketbeat.com - April 27 at 11:24 AM
Gold snaps five-week win streak, but bull run not over yet: MSGold snaps five-week win streak, but bull run not over yet: MS
msn.com - April 26 at 7:54 PM
Bank of New Hampshire Reduces Position in Morgan Stanley (NYSE:MS)Bank of New Hampshire Reduces Position in Morgan Stanley (NYSE:MS)
marketbeat.com - April 26 at 1:43 PM
Buy the Dip: A Magnificent 7 Stock Morgan Stanley RecommendsBuy the Dip: A 'Magnificent 7' Stock Morgan Stanley Recommends
theglobeandmail.com - April 26 at 9:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
The Goldman Sachs Group logo

The Goldman Sachs Group

NYSE:GS
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.
Morgan Stanley logo

Morgan Stanley

NYSE:MS
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.